摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-methoxyphenyl)-4-(octahydroquinolin-1(2H)-yl)-6-propylpyrimidin-2-amine | 1394805-05-0

中文名称
——
中文别名
——
英文名称
N-(4-methoxyphenyl)-4-(octahydroquinolin-1(2H)-yl)-6-propylpyrimidin-2-amine
英文别名
4-(3,4,4a,5,6,7,8,8a-octahydro-2H-quinolin-1-yl)-N-(4-methoxyphenyl)-6-propylpyrimidin-2-amine
N-(4-methoxyphenyl)-4-(octahydroquinolin-1(2H)-yl)-6-propylpyrimidin-2-amine化学式
CAS
1394805-05-0
化学式
C23H32N4O
mdl
——
分子量
380.533
InChiKey
VHJOIEWACJFRGI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.9
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    50.3
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
    申请人:Lee Hyun-Joo
    公开号:US20130331377A1
    公开(公告)日:2013-12-12
    The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT 4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.
    本发明提供了一种二氨基嘧啶生物或其药用可接受的盐,其制备方法,包含相同物质的药物组合物,以及其用途。该二氨基嘧啶生物或其药用可接受的盐作为5-HT4受体激动剂,因此可以有效地用于预防或治疗胃肠蠕动功能障碍,其中包括胃食管逆流病(GERD)、便秘、肠易激综合征(IBS)、消化不良、术后肠麻痹、胃排空延迟、胃轻瘫、肠假性梗阻、药物诱导的肠道延迟传输或糖尿病性胃松弛。
  • Diaminopyrimidine derivatives and processes for the preparation thereof
    申请人:Yuhan Corporation
    公开号:US10640490B2
    公开(公告)日:2020-05-05
    The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.
    本发明提供了一种二氨基嘧啶生物或其药学上可接受的盐、其制备工艺、包含二氨基嘧啶生物或其药学上可接受的盐的药物组合物及其用途。本发明的二氨基嘧啶生物或其药学上可接受的盐具有 5-HT4 受体激动剂的功能,因此可用于预防或治疗胃肠道运动功能障碍,即胃肠道疾病之一、如胃食管反流病(GERD)、便秘、肠易激综合征(IBS)、消化不良、术后回肠梗阻、胃排空延迟、胃瘫、肠假性梗阻、药物引起的转运延迟或糖尿病性胃 弛缓。
  • US9850227B2
    申请人:——
    公开号:US9850227B2
    公开(公告)日:2017-12-26
  • [EN] DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF<br/>[FR] DÉRIVÉS DE DIAMINOPYRIMIDINE ET LEURS PROCÉDÉS DE PRÉPARATION
    申请人:YUHAN CORP
    公开号:WO2012115478A2
    公开(公告)日:2012-08-30
    The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.
查看更多

同类化合物

铺地蜈蚣碱 诺利溴铵 蔓杉石松宁 羽扇豆碱 羽扇豆喃 硫双萍蓬定 甲基6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 狭叶碱 牡丹草佛明 溴化八氢5-甲基-1-[(2-甲基丙酰)氧代]-2H-喹嗪正离子 溴化八氢(1R,9aR)-5-甲基-1-(丙基桥氧基)-2H-喹嗪正离子 吲哚霉素 吐根胺 化合物 T29527 内-六氢-8-羟基-2,6-亚甲基-2H-喹嗪-3 八氢-喹啉嗪-3-羧酸乙酯 八氢-4H-喹嗪 八氢-4-甲基-2H-喹嗪 八氢-2H-喹嗪-1-基二甲基氨基甲酸酯盐酸(1:1) 八氢-1-(5-甲氧基-1H-吲哚-3-基)-2H-喹嗪 八氢-1-(5-甲基-1H-吲哚-3-基)-2H-喹嗪 乙基8-羟基-6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 乙基8-氯-4-氧代-4H-喹嗪-3-羧酸酯 乙基6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 乙基4-氧代-4H-喹嗪-3-羧酸酯 [(1R)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲硫醇 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-4-氨基-5-氯-2-甲氧基苯甲酰胺 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-2-甲氧基-5-氨基磺酰基苯甲酰胺 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-2,6-二甲氧基苯甲酰胺 N-[(E)-[(9aR)-六氢-2H喹嗪-1(6H)-亚基]甲基]-乙酰胺 N-[(1S,9aR)-八氢-2H-喹嗪-1-基甲基]-4-[(E)-苯基二氮烯基]-5,6,7,8-四氢萘-1-胺 8-氯-1-乙基-4-氧代-4H-喹啉嗪-3-羧酸乙酯 8-氨基-4-氧代-4H-喹嗪-3-羧酸 6,6-二甲基-2,3,4,7,8,9,10,10B-八氢-1H-环戊并[h]喹嗪 6,6-二甲基-1,2,3,4,7,7a,8,9,10,11,11a,11b-十二氢吡啶并[2,1-a]异喹啉 5-羟基-8-氮杂三环[5.3.1.03,8]十一烷-10-酮 5(2H)-异噻唑酮,3-甲基-4-戊基-(9CI) 4H-喹啉-3-羧酸,8-氯-1-环丙基-7-氟-9-甲基-4-氧代乙基酯 4-[(E)-(4-氟苯基)二氮烯基]-N-[(1S,9aR)-八氢-2H-喹嗪-1-基甲基]-5,6,7,8-四氢萘-1-胺 3-甲基-八氢-喹嗪 3-[二(2-噻吩基)亚甲基]八氢-2H-喹嗪 2H-喹嗪,1,3,4,6,7,9a-六氢- 2H-喹嗪,1,3,4,6,7,8-六氢-9-甲基- 2-羟基-3-甲基喹啉-4-酮 2-甲基-八氢-喹嗪 2-去氢金雀花碱 1-硝基-4-氧代-4H-喹嗪-3-甲酸乙酯 1-甲酰基-4-氧代-4H-羟基喹啉-3-羧酸乙酯 1-环丙基-7-氟-9-甲基-8-[(4aR,7aR)-八氢-6H-吡咯并[3,4-b]吡啶-6-基]-4-羰基-4H-喹嗪-3-羧酸 1-溴-4-氧代-4氢-喹嗪-3-甲酸乙酯